Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OXBT > SEC Filings for OXBT > Form 8-K/A on 22-Jan-2014All Recent SEC Filings

Show all filings for OXYGEN BIOTHERAPEUTICS, INC.

Form 8-K/A for OXYGEN BIOTHERAPEUTICS, INC.


22-Jan-2014

Financial Statements and Exhibits


Item 9.01 Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired

The audited historical financial statements of Phyxius as of December 31, 2012 and 2011 and for the year ended December 31, 2012, the period from January 18, 2011 (inception) through December 31, 2011, and the period from January 18, 2011 (inception) through December 31, 2012 are filed as Exhibit 99.2 and incorporated herein by reference.

The unaudited financial statements of Phyxius as of September 30, 2013 and December 31, 2012 and for the nine months ended September 30, 2013 and 2012 and the period from January 18, 2011 (inception) through September 30, 2013 are filed as Exhibit 99.3 and are incorporated herein by reference.

(b) Pro Forma Financial Information

The unaudited pro forma condensed combined balance sheet and statement of operations of the Company as of and for the six months ended October 31, 2013 and the unaudited pro forma condensed combined statement of operations of the Company for the year ended April 30, 2013 are filed as Exhibit 99.4 and are incorporated herein by reference.

(d) Exhibits.

Exhibit No.   Description
4.1*          Certificate of Designation of Series E Convertible Preferred Stock.
10.1*         Employment Agreement with John Kelley dated November 13, 2013.
10.2*         Second Amended and Restated Employment Agreement with Michael Jebsen
              dated November 13, 2013.
  23.1        Consent of WithumSmith+Brown, PC.
99.1*         Press Release dated November 14, 2013.
  99.2        Audited Financial Statements of Phyxius Pharma, Inc. as of December 31,
              2012 and 2011 and for the year ended December 31, 2012, the period from
              January 18, 2011 (inception) through December 31, 2011, and the period
              from January 18, 2011 (inception) through December 31, 2012.
  99.3        Unaudited Financial Statements of Phyxius Pharma, Inc. as of September
              30, 2013 and December 31, 2012 and for the nine months ended September
              30, 2013 and 2012 and the period from January 18, 2011 (inception)
              through September 30, 2013.
  99.4        Unaudited Pro Forma Condensed Combined Financial Information of Oxygen
              Biotherapeutics, Inc. as of and for the six months ended October 31,
              2013 and the unaudited pro forma condensed combined statement of
              operations of the Company for the year ended April 30, 2013.

* Filed with the Original Form 8-K, which was filed with the SEC on November 19, 2013.


  Add OXBT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OXBT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.